Ogbuji, V.; Paster, I.C.; Recio-Boiles, A.; Carew, J.S.; Nawrocki, S.T.; Chipollini, J.
Current Landscape of Immune Checkpoint Inhibitors for Metastatic Urothelial Carcinoma: Is There a Role for Additional T-Cell Blockade? Cancers 2024, 16, 131.
https://doi.org/10.3390/cancers16010131
AMA Style
Ogbuji V, Paster IC, Recio-Boiles A, Carew JS, Nawrocki ST, Chipollini J.
Current Landscape of Immune Checkpoint Inhibitors for Metastatic Urothelial Carcinoma: Is There a Role for Additional T-Cell Blockade? Cancers. 2024; 16(1):131.
https://doi.org/10.3390/cancers16010131
Chicago/Turabian Style
Ogbuji, Vanessa, Irasema C. Paster, Alejandro Recio-Boiles, Jennifer S. Carew, Steffan T. Nawrocki, and Juan Chipollini.
2024. "Current Landscape of Immune Checkpoint Inhibitors for Metastatic Urothelial Carcinoma: Is There a Role for Additional T-Cell Blockade?" Cancers 16, no. 1: 131.
https://doi.org/10.3390/cancers16010131
APA Style
Ogbuji, V., Paster, I. C., Recio-Boiles, A., Carew, J. S., Nawrocki, S. T., & Chipollini, J.
(2024). Current Landscape of Immune Checkpoint Inhibitors for Metastatic Urothelial Carcinoma: Is There a Role for Additional T-Cell Blockade? Cancers, 16(1), 131.
https://doi.org/10.3390/cancers16010131
